AISHWARYA RAJU: Open Payments
NPI 1023435278 · SUGAR LAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$480 in 26 payments from 11 companies in 2025. Trend: 2023 $656 · 2024 $1,550 · 2025 $480
Food & beverage: $480
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 4 | $90 |
| Corium, LLC | 6 | $61 |
| Axsome Therapeutics, Inc. | 3 | $60 |
| ABBVIE INC. | 3 | $55 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $49 |
| Teva Pharmaceuticals USA, Inc. | 2 | $43 |
| Neos Therapeutics, LP | 2 | $31 |
| E.R. Squibb & Sons, L.L.C. | 1 | $25 |
| Alkermes, Inc. | 1 | $25 |
| Tempus AI, Inc | 1 | $25 |
Products named: Qelbree, Azstarys, Auvelity, VRAYLAR, CAPLYTA, AUSTEDO XR, Adzenys XR-ODT, COBENFY.
Industry payments across TX — which companies pay providers there.
